Cardiac glycoside
| Cardiac glycoside | |
|---|---|
| Drug class | |
| The general structure of a cardiac glycoside molecule. | |
| Class identifiers | |
| Use | Congestive heart failure | 
| ATC code | C01A | 
| Biological target | Na+/K+-ATPase | 
| External links | |
| MeSH | D002301 | 
| Legal status | |
| In Wikidata | |
Cardiac glycosides are a class of organic compounds that increase the output force of the heart and decrease its rate of contractions by inhibiting the cellular sodium-potassium ATPase pump. Their beneficial medical uses include treatments for congestive heart failure and cardiac arrhythmias; however, their relative toxicity prevents them from being widely used. Most commonly found as defensive poisons in several plant genera such as Digitalis (the foxgloves) and Asclepias (the milkweeds), these compounds nevertheless have a diverse range of biochemical effects regarding cardiac cell function and have also been suggested for use in cancer treatment.